165 filings
Page 2 of 9
25-NSE
1idcdak
21 Dec 22
Exchange delisting
6:08am
8-K
9av2dva8t4ykx 18y9
2 Dec 22
Departure of Directors or Certain Officers
4:19pm
8-K
czwhrsblmq
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
NT 10-Q
01zuf
15 Nov 22
Notice of late quarterly filing
4:21pm
8-K
mov9thx34adf jz85wa
8 Nov 22
Entry into a Material Definitive Agreement
5:21pm
8-K
a9gzbpmlk
31 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:21pm
8-K
2ch5jw
24 Oct 22
Bankruptcy or Receivership
8:02am
8-K
lhack77yber7h
7 Oct 22
Entry into a Material Definitive Agreement
5:20pm
8-K
l6dv26 7o
27 Sep 22
Other Events
5:00pm
8-K
7ffmgp7 qkhvct625s
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am
8-K
jb9n7pgsdpflhbhjxkn
8 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:14pm
8-K
hn1h4yu3qh7cw4eg1b
5 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
3q24hw2masqo 6gq4da
20 May 22
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
0jxt8nyut10064wmzyr
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
2myit7u2x 25
4 Apr 22
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
4:35pm
8-K
4mqiqc4
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm